CoChat

Review of structural design guiding the development of lipid nanoparticles for nucleic acid delivery

Cárdenas, Marité, Campbell, Richard A., Yanez Arteta, Marianna, Lawrence, M. Jayne, Sebastiani, Federica · 2023 · Current Opinion in Colloid & Interface Science
Cited by 103

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cocis.2023.101705

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 43

  1. Friedmann, 1992, A brief history of gene therapy, Nat Genet, 2, 93, 10.1038/ng1092-93 · DOI · Paper page
  2. Davidson, 2011, Current prospects for RNA interference-based therapies, Nat Rev Genet, 12, 329, 10.1038/nrg2968 · DOI · Paper page
  3. Juliano, 2014, Cellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology, Nucleic Acid Therapeut, 24, 101, 10.1089/nat.2013.0463 · DOI · Paper page
  4. Mohammadinejad, 2019, Necrotic, apoptotic and autophagic cell fates triggered by nanoparticles, Autophagy, 15, 4, 10.1080/15548627.2018.1509171 · DOI · Paper page
  5. Vaheri, 1965, Infectious poliovirus RNA: a sensitive method of assay, Virology, 27, 434, 10.1016/0042-6822(65)90126-1 · doi:10.1016/0042-6822(65)90126-1
  6. Rädler, 1997, Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes, Science, 275, 810, 10.1126/science.275.5301.810 · DOI · Paper page
  7. Koltover, 1998, An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery, Science, 281, 78, 10.1126/science.281.5373.78 · DOI · Paper page
  8. Radhakrishnan, 2022, Influence of micellar size on the structure of surfactant-DNA complexes, Phys Rev E, 105, 10.1103/PhysRevE.105.064504 · doi:10.1103/physreve.105.064504
  9. Kim, 2015, Topologically active siRNA delivery, ACS Nano, 9, 10214, 10.1021/acsnano.5b03902 · DOI
  10. Tang, 1998, Introduction of a disulfide bond into a cationic lipid enhances transgene expression of plasmid DNA, Biochem Biophys Res Commun, 242, 141, 10.1006/bbrc.1997.7923 · DOI
  11. Koynova, 2007, Lipoplex formulation of superior efficacy exhibits high surface activity and fusogenicity, and readily releases DNA, Biochim Biophys Acta Biomembr, 1768, 375, 10.1016/j.bbamem.2006.10.016 · DOI
  12. Urits, 2020, A review of patisiran (ONPATTRO®) for the treatment of polyneuropathy in people with hereditary transthyretin amyloidosis, Neurol. Ther., 9, 301, 10.1007/s40120-020-00208-1 · DOI · Paper page
  13. Ganesan, 2017, Lipid nanoparticles: different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery, Sustain. Chem. Pharm., 6, 37, 10.1016/j.scp.2017.07.002 · DOI · Paper page
  14. Mourdikoudis, 2018, Characterization techniques for nanoparticles: comparison and complementarity upon studying nanoparticle properties, Nanoscale, 10, 12871, 10.1039/C8NR02278J · DOI · Paper page
  15. Jia, 2021, Enabling online determination of the size-dependent RNA content of lipid nanoparticle-based RNA formulations, J Chromatogr, B: Anal Technol Biomed Life Sci, 1186, 10.1016/j.jchromb.2021.123015 · DOI
  16. Hedegaard, 2018, Fluorophore labeling of a cell-penetrating peptide significantly alters the mode and degree of biomembrane interaction, Sci Rep, 8, 6327, 10.1038/s41598-018-24154-z · doi:10.1038/s41598-018-24154-z
  17. Majzoub, 2015, Fluorescence microscopy colocalization of lipid-nucleic acid nanoparticles with wildtype and mutant Rab5-GFP: a platform for investigating early endosomal events, Biochim. Biophys. Acta, 1848, 1308, 10.1016/j.bbamem.2015.03.001 · DOI
  18. Munson, 2021, A high-throughput Galectin-9 imaging assay for quantifying nanoparticle uptake, endosomal escape and functional RNA delivery, Commun. Biol., 4, 211, 10.1038/s42003-021-01728-8 · DOI
  19. Sarode, 2022, Predictive high-throughput screening of PEGylated lipids in oligonucleotide-loaded lipid nanoparticles for neuronal gene silencing, Nanoscale Adv, 4, 2107, 10.1039/D1NA00712B · DOI
  20. Quagliarini, 2022, Mechanistic insights into the superior DNA delivery efficiency of multicomponent lipid nanoparticles: an in vitro and in vivo study, ACS Appl Mater Interfaces, 14, 56666, 10.1021/acsami.2c20019 · DOI
  21. Wilson, 2015, Real time measurement of PEG shedding from lipid nanoparticles in serum via NMR spectroscopy, Mol Pharm, 12, 386, 10.1021/mp500400k · DOI
  22. Paracini, 2023, Structural characterization of nanoparticle-supported lipid bilayer arrays by grazing incidence X-ray and neutron scattering, ACS Appl Mater Interfaces, 10.1021/acsami.2c18956 · doi:10.1021/acsami.2c18956
  23. Daniel, 2022, Quality by Design for enabling RNA platform production processes, Trends Biotechnol, 40, 1213, 10.1016/j.tibtech.2022.03.012 · DOI
  24. Clifton, 2020, Design and use of model membranes to study biomolecular interactions using complementary surface-sensitive techniques, Adv Colloid Interface Sci, 277, 10.1016/j.cis.2020.102118 · DOI
  25. Spadea, 2022, Nucleic acid-loaded lipid nanoparticle interactions with model endosomal membranes, ACS Appl Mater Interfaces, 14, 30371, 10.1021/acsami.2c06065 · DOI
  26. Aliakbarinodehi, 2022, Interaction kinetics of individual mRNA-containing lipid nanoparticles with an endosomal membrane mimic: dependence on pH, protein corona formation, and lipoprotein depletion, ACS Nano, 16, 20163, 10.1021/acsnano.2c04829 · DOI
  27. Sebastiani, 2021, Screening of the binding affinity of serum proteins to lipid nanoparticles in a cell free environment, J Colloid Interface Sci
  28. Kulkarni, 2019, On the role of helper lipids in lipid nanoparticle formulations of siRNA, Nanoscale, 11, 21733, 10.1039/C9NR09347H · DOI · Paper page
  29. Li, 2023, Acidification-induced structure evolution of lipid nanoparticles correlates with their in vitro gene transfections, ACS Nano
  30. Semple, 2005, Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic Acid, J Pharmacol Exp Therapeut, 312, 1020, 10.1124/jpet.104.078113 · DOI · Paper page
  31. Chen, 2016, Measurement of pre-existing IgG and IgM antibodies against polyethylene glycol in healthy individuals, Anal Chem, 88, 10661, 10.1021/acs.analchem.6b03109 · DOI · Paper page
  32. Francia, 2020, The biomolecular corona of lipid nanoparticles for gene therapy, Bioconjugate Chem, 31, 2046, 10.1021/acs.bioconjchem.0c00366 · DOI · Paper page
  33. Parodi, 2015, Enabling cytoplasmic delivery and organelle targeting by surface modification of nanocarriers, Nanomedicine, 10, 1923, 10.2217/nnm.15.39 · DOI
  34. Anderluzzi, 2022, The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency, J Contr Release, 342, 388, 10.1016/j.jconrel.2021.12.008 · DOI
  35. Trollmann, 2022, mRNA lipid nanoparticle phase transition, Biophys J, 121, 3927, 10.1016/j.bpj.2022.08.037 · DOI
  36. Davies, 2021, Functionalized lipid nanoparticles for subcutaneous administration of mRNA to achieve systemic exposures of a therapeutic protein, Mol Ther Nucleic Acids, 24, 369, 10.1016/j.omtn.2021.03.008 · DOI
  37. Oude Blenke, 2023, The storage and in-use stability of mRNA vaccines and therapeutics: not A cold case, J Pharmaceut Sci, 112, 386, 10.1016/j.xphs.2022.11.001 · DOI · Paper page
  38. Packer, 2021, A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems, Nat Commun, 12, 6777, 10.1038/s41467-021-26926-0 · DOI · Paper page
  39. Suzuki, 2022, Design and lyophilization of lipid nanoparticles for mRNA vaccine and its robust immune response in mice and nonhuman primates, Mol Ther Nucleic Acids, 30, 226, 10.1016/j.omtn.2022.09.017 · DOI
  40. Zhigaltsev, 2012, Bottom-up design and synthesis of limit size lipid nanoparticle systems with aqueous and triglyceride cores using millisecond microfluidic mixing, Langmuir, 28, 3633, 10.1021/la204833h · DOI · Paper page
  41. Johnson, 2003, Chemical processing and micromixing in confined impinging jets, AIChE J, 49, 2264, 10.1002/aic.690490905 · DOI · Paper page
  42. An, 2022, On the influence of nucleic acid backbone modifications on lipid nanoparticle morphology, Langmuir, 38, 14036, 10.1021/acs.langmuir.2c01492 · DOI
  43. Hassett, 2021, Impact of lipid nanoparticle size on mRNA vaccine immunogenicity, J Contr Release, 335, 237, 10.1016/j.jconrel.2021.05.021 · DOI · Paper page

Cited by

See all 103

Metadata

Authors
Cárdenas, M., Campbell, R. A., Yanez Arteta, M., Lawrence, M. J., & Sebastiani, F.
Venue
Current Opinion in Colloid & Interface Science
Publisher
Elsevier BV
Published
2023-08
Volume
66
Pages
101705
ISSN
1359-0294
Cited by
103
References
22
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.